Home/Filings/4/0001409916-19-000011
4//SEC Filing

Springfield James 4

Accession 0001409916-19-000011

CIK 0001409916other

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 6:09 PM ET

Size

5.5 KB

Accession

0001409916-19-000011

Insider Transaction Report

Form 4
Period: 2019-01-22
Springfield James
Chief Executive Officer
Transactions
  • Award

    Stock Options (Right to Buy)

    2019-01-22+250,000250,000 total
    Exercise: $0.44From: 2020-01-01Exp: 2029-01-22Common Stock (250,000 underlying)
Footnotes (2)
  • [F1]Stock options granted at $0.44 on a 5-day volume weighted average price (VWAP) for 5 business days - 01/14/19 - 01/18/19.
  • [F2]Stock options vest as to 83,333.33 on January 1, 2020, 83,333.33 on January 1, 2021, and 83,333.33 on January 1, 2022.

Issuer

Nobilis Health Corp.

CIK 0001409916

Entity typeother

Related Parties

1
  • filerCIK 0001764822

Filing Metadata

Form type
4
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 6:09 PM ET
Size
5.5 KB